Understand the research
without the jargon wall.
KritRNA is an early research company. It does not currently offer a treatment, clinical trial or patient-enrolment programme. These resources explain the science and the boundaries clearly.
Genes, proteins and premature stops
A plain-language path for families and non-specialists.
ScienceHow suppressor tRNA works
A deeper explanation of readthrough, aminoacylation, release-factor competition and safety.
DefinitionsScientific glossary
Clear definitions for PTC, NMD, aaRS, readthrough, translation and related terms.
ExploreDisease and gene explorer
Educational examples of selected nonsense-mutation contexts in HBB, DMD and CFTR.
CommunityPatient-organisation collaboration
How advocacy groups and communities can work with KritRNA without submitting medical records.
QuestionsAsk KritRNA
Use the grounded public-information assistant and inspect the source links beneath answers.
जीन में समय से पहले आया “स्टॉप” संकेत प्रोटीन बनना रोक सकता है।
KritRNA ऐसे suppressor tRNA डिज़ाइन पर शोध कर रहा है जो चुने हुए premature stop codon पर ribosome को आगे पढ़ने में मदद कर सकें। यह अभी शोध का चरण है—उपचार उपलब्ध नहीं है।
An early “stop” signal can interrupt protein production.
KritRNA is researching suppressor-tRNA designs intended to help the ribosome continue past selected premature stops. This remains research—not an available treatment.